- Are New Treatment Options for Beta Thalassemia Ready for Widespread Use?
Saturday, June 1st, 2019
Patients with transfusion-dependent beta thalassemia, the most severe form of the disease, require lifelong management with red blood cell (RBC) transfusions, presenting a substantial cost and burden to patients. The only curative treatment for patients with transfusion-dependent beta thalassemia is allogeneic hematopoietic cell transplantation (alloHCT), which also is associated with a variety of adverse events. [...]
- Pulling Back the Curtain: Alexis Thompson, MD, MPH
Saturday, December 1st, 2018
In this edition, Alexis A. Thompson, MD, MPH, speaks about her career studying and working with patients with hemoglobin disorders – and discovering a centuries-old link to medicine. Hear more from our interview with Dr. Thompson in Sound Bites.